
Dapixa M 10mg/500mg Tablet ER
Marketer
Tas Med India Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Dapixa M 10mg/500mg Tablet ER
Metformin/Saxagliptin 10mg/500mg Extended-Release Tablets are a dual-action medication for managing type 2 diabetes. This combination effectively lowers elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to cardiovascular health. These tablets can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation should only occur under medical supervision, as abrupt cessation can lead to dangerously high blood sugar and potentially serious consequences such as kidney failure or vision impairment. This medication forms part of a comprehensive diabetes management plan that must include a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea), and dehydration (mitigated by increased fluid intake). Genital fungal infections may occur; diligent hygiene practices are recommended. Prior to commencing treatment, individuals with kidney or liver disease, urinary tract infections, or those using diuretics should consult their physician. Pregnant or lactating women should seek medical advice. Excessive alcohol consumption should be avoided due to potential increased side effect risk. Regular blood glucose monitoring is essential during treatment.
Uses of Dapixa M 10mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Dapixa M 10mg/500mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dapixa M 10mg/500mg Extended-Release Tablets with a meal.
Common Side effects of Dapixa M 10mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapixa M 10mg/500mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Dapixa M 10mg/500mg Extended-Release Tablets should be administered with a meal.
How Dapixa M 10mg/500mg Tablet ER works:
Extended-release Dapixa M tablets (10mg/500mg) combine dapagliflozin and metformin to manage blood glucose. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action optimizes glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Dapixa M 10mg/500mg Tablet ER ingestion poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dapixa M 10mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapixa M 10mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Dapixa M 10mg/500mg Extended-Release tablets. Dosage modification of Dapixa M 10mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Dapixa M 10mg/500mg Extended-Release tablets cautiously. Dosage modification of Dapixa M 10mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Dapixa M 10mg/500mg Tablet ER :
Should you forget to take a Dapixa M 10mg/500mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapixa M 10mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
